View printer-friendly version << Back
MEDNAX Announces Acquisition of Anesthesiology Practice in New York

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Jun. 20, 2016-- MEDNAX, Inc. (NYSE: MD), today announced the acquisition of Westchester Anesthesiologists, PC, a private physician group practice based in White Plains, N.Y. The practice was acquired by one of the company's affiliated professional contractors in New York.

Westchester Anesthesiologists provides anesthesia care across a wide spectrum of subspecialty areas in Westchester County. The practice employs 31 full-time clinicians (27 anesthesiologists and 4 anesthetists) that provide services to White Plains Hospital, a 292-bed health care organization. The practice also provides services to Rye Ambulatory Surgery Center, Surgical Specialty Center of Westchester and WESTMED Medical Group.

Westchester Anesthesiologists’ inpatient and outpatient anesthesia services include general, cardiac, endoscopies, obstetrics and cosmetic.

“Our group has provided the highest quality of anesthesia care to our surrounding community for more than 30 years, and we expect to continue that legacy as we partner with MEDNAX to support and guide us through this new and complex era of health care,” said Mitchell Reuben, M.D., who will serve as medical director for the practice. “MEDNAX’s well-developed infrastructure will help us not only provide value added services to our hospital, facilities and patients but also further enhance the care we deliver through leading-edge data collection as well as research, education and quality initiatives and outcomes.”

This acquisition adds to the services MEDNAX provides, through its affiliated professional contractors, across multiple specialties which include anesthesiology, neonatology, hearing screen and radiology services.

This was a cash transaction, and it is expected to be immediately accretive to earnings. No additional terms of the transaction were disclosed.

With this acquisition, seven physician group practices have become part of MEDNAX in 2016.


MEDNAX, Inc. is a national health solutions partner comprised of the nation's leading providers of physician services. Physicians and advanced practitioners practicing as part of MEDNAX are reshaping the delivery of care within their specialties and subspecialties, using evidence-based tools, continuous quality initiatives, clinical research and telemedicine to enhance patient outcomes and provide high-quality, cost-effective care. The Company was founded in 1979, and today, through its affiliated professional corporations, MEDNAX provides services through a network of more than 3,300 physicians in all 50 states and Puerto Rico. In addition to its national physician network, MEDNAX provides services to healthcare facilities and physicians in over 40 states through two complementary businesses, consisting of a revenue cycle management company and a consulting services company. Additional information is available at

Certain statements and information in this press release may be deemed to contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies, and all statements, other than statements of historical facts, that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future. These statements are often characterized by terminology such as “believe”, “hope”, “may”, “anticipate”, “should”, “intend”, “plan”, “will”, “expect”, “estimate”, “project”, “positioned”, “strategy” and similar expressions, and are based on assumptions and assessments made by MEDNAX’s management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Any forward-looking statements in this press release are made as of the date hereof, and MEDNAX undertakes no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. Important factors that could cause actual results, developments, and business decisions to differ materially from forward-looking statements are described in MEDNAX’s most recent Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q, including the sections entitled “Risk Factors”, as well MEDNAX’s current reports on Form 8-K, filed with the Securities and Exchange Commission.

Source: MEDNAX, Inc.

Charles Lynch, 954-384-0175, x 5692
Vice President, Strategy and Investor Relations